(2026). Consideration of the limitations of cost-effectiveness analysis for severe-rare disease drugs and potential solutions: A structured literature review. Health Economics Review.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Consideration of the Limitations of Cost-effectiveness Analysis for Severe-rare Disease Drugs and Potential Solutions: A Structured Literature Review."
Health Economics Review 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Consideration of the Limitations of Cost-effectiveness Analysis for Severe-rare Disease Drugs and Potential Solutions: A Structured Literature Review."
Health Economics Review, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.